Regular three monthly oral ciprofloxacin in adult cystic fibrosis patients infected with Pseudomonas aeruginosa (Q72729801)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8290742%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

title

Regular three monthly oral ciprofloxacin in adult cystic fibrosis patients infected with Pseudomonas aeruginosa (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8290742%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

Pseudomonas aeruginosa

object named as

Pseudomonas aeruginosa

1 reference

C D Sheldon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8290742%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

B K Assoufi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8290742%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

M E Hodson

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8290742%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

publication date

1 November 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8290742%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8290742%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8290742%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8290742%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

587-593

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8290742%20AND%20SRC:MED&resulttype=core&format=json

Sputum changes associated with therapy for endobronchial exacerbation in cystic fibrosis

28 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980261-6

7 January 2021

Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980261-6

7 January 2021

Pharmacokinetics and pharmacodynamics of ciprofloxacin in cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980261-6

7 January 2021

Pharmacokinetics and sputum penetration of ciprofloxacin in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980261-6

7 January 2021

Oral ciprofloxacin compared with conventional intravenous treatment for Pseudomonas aeruginosa infection in adults with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980261-6

7 January 2021

Efficacy of oral fluoroquinolones versus conventional intravenous antipseudomonal chemotherapy in treatment of cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980261-6

7 January 2021

Changing susceptibility of Pseudomonas aeruginosa isolates from cystic fibrosis patients with the clinical use of newer antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980261-6

7 January 2021

Oral ciprofloxacin therapy of infections due to Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980261-6

7 January 2021

The efficacy and safety of ciprofloxacin and ofloxacin in chronic Pseudomonas aeruginosa infection in cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980261-6

7 January 2021

Heterogeneity of antibiotic resistance in mucoid isolates of Pseudomonas aeruginosa obtained from cystic fibrosis patients: role of outer membrane proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980261-6

7 January 2021

An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980261-6

7 January 2021

Reduced virulence in ciprofloxacin-resistant variants of Pseudomonas aeruginosa strains

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980261-6

7 January 2021

Inhibition of Pseudomonas aeruginosa exoenzyme expression by subinhibitory antibiotic concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980261-6

7 January 2021

Subinhibitory antibiotics reduce Pseudomonas aeruginosa tissue injury in the rat lung model

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980261-6

7 January 2021

Selective inhibition of the accumulation of extracellular proteases of Pseudomonas aeruginosa by gentamicin and tobramycin

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980261-6

7 January 2021

The effect of sublethal concentrations of aminoglycosides on adherence of Pseudomonas aeruginosa to hamster tracheal epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980261-6

7 January 2021

10.1016/S0954-6111(05)80261-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8290742%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference